The single most useful distinction in this category is central versus vascular. Tadalafil and sildenafil are PDE5 inhibitors: they preserve cyclic GMP and therefore smooth-muscle relaxation in vascular beds. They act on blood flow and require existing arousal signalling to work with.
PT-141 acts centrally at melanocortin receptors in the nervous system, on arousal itself rather than on the vascular response. That makes it mechanistically complementary to PDE5 inhibition rather than an alternative, which is why the two appear together in the literature.
Underlying hormonal status sits beneath both. Low testosterone, elevated prolactin and thyroid dysfunction all present as reduced libido, and none of them are addressed by either mechanism above. Cabergoline appears in this category for exactly that reason.
What to weigh up
Duration is the practical difference
Tadalafil is around 17.5 hours, sildenafil around 4. Same mechanism, very different planning.
Nitrates are an absolute contraindication
PDE5 inhibitors with nitrates cause severe hypotension. This is not a caution, it is a hard contraindication.
Check hormones before compounds
Prolactin, thyroid and testosterone explain a substantial share of cases and are simple to measure.
PT-141 is not a PDE5 inhibitor
It acts on a different system entirely and behaves differently as a result.
Stocked for this goal
Caber (30x0.5mg)out of stock
Cialisin stock
HCGin stock
HMGin stock
Proviron (Pharma)out of stock
Quanta Pharma Provironin stock
Quanta Pharma PT-141 10mgin stock
Quanta Pharma Testosterone Cypionatein stock
Quanta Pharma Testosterone Enanthatein stock
Quanta Pharma Testosterone Isocaproatein stock
Quanta Testosterone Undecanoate (TRT Choice)out of stock
SerenQ Kisspeptin-10 10mg Peptide Penout of stock
SerenQ PT-141 10mg Peptide Penout of stock
Viagrain stock
Go deeper
This page covers what serves the goal. For what each compound actually is - class, mechanism, half-life and storage - see the reference library.